The Institutes for Pharmaceutical Discovery LLC was operated as a discovery research company. The company was founded in 1995 and was headquartered in Branford, CT.

Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

The Korea Institute of Ocean Science and Technology (KIOST) with its headquarters in Busan, South Korea, has driven development of the marine sciences and technology of Korea for almost 50 years since its establishment in 1973. Formerly known as the Korean Ocean Research and Development Institute (KORDI), it started functioning with the new name of Korea Institute of Ocean Science and Technology from July 1, 2012.

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Develops and manufactures human therapeutics to fill unmet medical needs

Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute in Daejeon, South Korea. It is dedicated to biotechnology research across a broad span of expertise, from basic studies for the fundamental understanding of life phenomena to applied studies such as drug discovery, novel biomaterials, integrated biotechnology and bioinformation.

CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company operates through the following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services. The New Drug Development division engages in the development of anti-cancer remedies, antibiotics, diabetes treatments, remedies for hypoxia diseases, obesity treatment medicines and others. Its products offered include Acelex. The company was founded by Cho Joong Myung and Ro Seong Gu on July 7, 2000 and is headquartered in Seongnam, South Korea.

Ceptyr, Inc was founded to focus on developing drugs against protein tyrosine phosphatases (PTPs), a largely unexplored niche in pharmaceutical development.

Sirna Therapeutics, Inc. was a San Francisco, California based biotechnology company that explored the use of RNA interference in human disease therapy. Sirna's development pipeline includes several small interfering RNA (siRNA) drugs, thought to stably silence the expression of specific disease-related genes. Sirna's clinical trial of an siRNA-based treatment for age-related macular degeneration is the first such trial for an siRNA drug.

Foshan Saiweis Pharmaceutical Technology Co., Ltd., established on 2014-11-12, Business scope includes services:Medical Technology Research,to develop,transfer,drug consultation,Nutrition and Health Consulting,market survey,Conference and Exhibition Services,Intellectual Property Services,Large-scale celebration event planning,Corporate Image Planning;retail:fruit,vegetable,daily necessities,cosmetic,Class I medical device;Engage in drug retail with valid approval certificates,Health food management,food circulation,Operation of Class II and Class III medical devices.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Baicheng Pharmaceuticals is a drug R&D manufacturer, focusing on drug preclinical research, including process research, quality research and stability research of raw materials and preparations. Its main business includes independent research and development, joint research and development, entrusted technology development and technology transfer, research and development The targets specifically include the research and development of innovative drugs and the research and development of generic drugs.

Nantong Yaoxiang Technology Co., Ltd., established on 2016-11-21, Business scope includes biotechnology,Medical Technology Development,consult,transfer;consumer product,Cosmetic technology research and development,technology transfer,technical consulting;Medical Research and Experimental R&D;Online Trade Agent;Chemical raw materials(Does not contain dangerous goods),Chemical Products(Does not contain dangerous goods),Cosmetic sales;Class I medical device import and export business(Except for goods that are restricted by the state to be operated by enterprises or prohibited from import and export);food business;cosmetic,Daily necessities sales;Internet information service;Network Technology Consulting Services;Market information consultation;Enterprise Marketing Planning.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:patent agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Intellectual Property Services;Trademark agency;copyright agent;Artificial intelligence innovation and innovation service platform(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Yaoda Biotechnology Co., Ltd., established on 2013-04-25, Business scope includes general items:engaged in biotechnology,Medical Technology,Information Technology,electronic technology,Technology development in the field of environmental technology,technical consulting,Technical Services,technology transfer,Business Management Consulting,Market information consultation and investigation(Do not engage in social investigation,social research,poll,opinion poll),marketing planning,Corporate Image Planning,account Serive,Exhibition display service,e-commerce(Not to engage in financial business),design,Create various advertisements,Ticket agent,Daily necessities,electronic product,crafts(Except for ivory and its products),Office Supplies,Class I medical device,Instrumentation,Chemical products and raw materials(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals)promotion of.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Nuowei Technology (Beijing) Co., Ltd., established on 2014-04-03, The scope of business includes subtotipotent stem cells,mesenchymal stem cells,hematopoietic stem cell storage,Gene Sequencing,cell expansion,in vitro cell culture,cell therapy,gene therapy cell line,cell culture medium,cell preparation,storage technology,Cell and Bioengineering Products,Technology Development of Gene Technology,technical consulting,Technical Services,technology transfer;Technical testing;Medical Research and Experimental Development;buisness planning;Provide conference services;Equipment Repair;data processing(Bank Card Center in Data Processing,PUEvalue in1.5Except for the above cloud computing data centers);Sales of medical devices Class I,Class II;Sales of Class III medical devices.(Market entities independently choose business projects in accordance with the law,Carry out business activities;Items subject to approval by law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the industrial policies of the state and this city.)